Avantect® Pancreatic Cancer Test
Pancreatic cancer early detection
Key Facts
About Bcal Diagnostics
Australian biotech delivering AI‑enhanced blood tests for early breast, pancreatic, and ovarian cancer detection.
View full company profileAbout ClearNote Health
ClearNote Health is a commercial-stage diagnostics company leveraging its unique epigenomics platform to detect high-mortality cancers early via a simple blood draw. The company's core technology measures 5-hydroxymethylcytosine (5hmC) modifications in cell-free DNA, providing a sensitive and specific signal of developing cancer. Key achievements include NYSDOH approval and CMS reimbursement for its Avantect tests, selection for the NCI's Vanguard study, and a strategic focus on pancreatic and ovarian cancers. The company is expanding its leadership and commercial footprint to drive clinical adoption.
View full company profileTherapeutic Areas
Other Pancreatic cancer early detection Drugs
| Drug | Company | Phase |
|---|---|---|
| Pancreatic Cancer Detection Test | Mainz Biomed | Research |